The Role of <sup>18</sup>F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis

<div>(a) SROC for NAC response prediction in primary breast cancer by <sup>18</sup>F-FDG PET/CT. (b) SROC for NAC response prediction in primary breast cancer by MRI.</div>

BioMed Research International

fig6

Figure 6

Figure 6: The Role of <sup>18</sup>F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis 

Figure 6 | The Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis 